Quick Answer
Gout is caused by uric acid crystal deposition in joints. Effective management combines acute attack treatment with long-term urate-lowering therapy.
Medically reviewed by Dr. Shree Narayan Yadav • NMC 14227 • Kathmandu Neurology Clinic & Cognitive Center
Gout is a form of inflammatory arthritis caused by the deposition of monosodium urate crystals in joints and surrounding tissues, resulting from chronic hyperuricemia (elevated blood uric acid levels). It typically presents as sudden, severe joint pain — most commonly affecting the big toe — with swelling, redness, and warmth. Gout attacks are intensely painful but usually resolve within one to two weeks if untreated. Recurrent attacks can lead to tophi (uric acid deposits), joint damage, and kidney stones.
Acute gout management focuses on reducing inflammation quickly. Nonsteroidal anti-inflammatory drugs (NSAIDs), colchicine, and corticosteroids are first-line options, depending on kidney function and other medical conditions. These should be started as soon as possible after symptom onset for maximum effectiveness. Ice application and joint rest can provide adjunctive relief.
Dr. Shree Narayan Yadav — consultant physician & joint and autoimmune disease specialist at Kathmandu Neurology Clinic & Cognitive Center provides evidence-based evaluation for gout.
Long-term management centers on urate-lowering therapy (ULT) to prevent future attacks and joint damage. Allopurinol and febuxostat reduce uric acid production, while probenecid promotes uric acid excretion. The target serum urate level is below 6 mg/dL. Lifestyle modifications — limiting alcohol, reducing purine-rich foods, maintaining hydration, and managing weight — complement pharmacological therapy.
This article is educational and does not replace individual medical advice.
Frequently asked questions
Answers reviewed by Dr. Jitendra Prasad Yadav • MBBS, MD (Internal Medicine), FICN (Neurology), FCNV, FIHM • NMC 8029
Diet contributes to hyperuricemia but is not the sole cause. Genetics, kidney function, medications, and metabolic factors all play a role. Many patients with high urate levels never develop gout, while some with normal levels can have flares.
With consistent urate-lowering therapy maintaining serum urate below 6 mg/dL, existing urate deposits can dissolve and flares can be largely prevented. Most patients require long-term treatment.
Migraine is a neurological condition; headache is one feature. Associated symptoms and functional impact are important for diagnosis.
Aura refers to visual, sensory, or speech symptoms that precede the headache in some people. Both types are migraine; the presence of aura may influence management discussion.
More: All FAQs → · Ask Dr. Jitendra →
Related articles
Gout Diet and Lifestyle: Practical Strategies to Lower Uric Acid
Evidence-based dietary and lifestyle modifications for gout management — foods to limit, foods to include, hydration, weight management, and exercise.
Joint Pain: Inflammatory vs Mechanical — How to Tell the Difference
Understanding the difference between inflammatory and mechanical joint pain, and why the distinction guides diagnosis and treatment.
Osteoarthritis vs Rheumatoid Arthritis: Key Differences That Matter
How to distinguish osteoarthritis from rheumatoid arthritis — causes, symptoms, diagnosis, and why the distinction determines treatment.
Medical Disclaimer
Content on this website is for general educational purposes only and does not constitute medical advice, diagnosis, or treatment. It is not a substitute for evaluation by a qualified healthcare professional. Always seek the advice of your physician or other qualified provider with any questions regarding a medical condition. Never disregard professional medical advice or delay seeking it because of something you have read on this website. In case of a medical emergency, contact emergency services immediately. No doctor–patient relationship is established by use of this site or by contacting the clinic through the site.
References & Review
Reviewed by Dr. Jitendra Prasad Yadav • Last reviewed: 2026-09-04
- International Classification of Headache Disorders, 3rd edition (ICHD-3).
- Harrison's Principles of Internal Medicine — Neurology sections.
- American Academy of Neurology guidelines for selected conditions (where applicable).
Content is educational and aligns with standard medical references; individual evaluation may vary. External links provide context and do not imply endorsement.